Research
Hormonal
Treatment of metabolic changes at menopause requires a flexible long-term strategy.
Practitioners should develop adaptable treatment plans for managing menopause-related metabolic changes.
StrongSupportsmedium confidence
Treatment of these changes requires a flexible long-term strategy.
Why this rating
The abstract is from a narrative review, which synthesizes existing research.
Source
Fat mass, weight and body shape changes at menopause – causes and consequences: a narrative review
Anna Fenton et al. · Climacteric · 2023
DOI 10.1080/13697137.2023.2178892
reviewCited 24×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →